Diseases Market Research

Reportbuyer.com helps you stay ahead with advanced reports on Diseases. Information includes Competitive Positioning, Stakeholder Opinions and Future Market Watch.

Stay up-to-date with new products added to this category

Results 1 - 100 of 433

previous 1 2 3 4 5 next

last

Title	Date	Price
FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART) Competitor Analysis	Nov 2009	£180
TGF-R Agonists and Antagonists Competitor Analysis	Nov 2009	£180
Alzheimer's Disease New Drugs, Markets and Companies	Oct 2009	£1,805
Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals), The	Oct 2009	£2,105
Infectious Diseases Drugs Markets	Oct 2009	£2,075
Competitor Analysis: EGF-R Agonists and Antagonists	Oct 2009	£270
The Diabetes Market Outlook To 2014 Market Dynamics, Competitive Landscape, Emerging Therapies	Sep 2009	£2,305
Competitor Analysis: Her2 Receptor Antagonists	Sep 2009	£225
Chinese Markets for Colon Cancer Treatment Drugs	Sep 2009	£2,405
Chinese Markets for Cervical Cancer Treatment Drugs	Sep 2009	£2,405
World Neurodegenerative Diseases Market 2009-2024	Sep 2009	£1,499
Chinese Markets for Bladder Cancer Treatment Drugs	Sep 2009	£2,405
Chinese Markets for Brain Cancer Treatment Drugs	Sep 2009	£2,405
The Spanish Cancer Diagnostics Market	Sep 2009	£2,465
Leading Cancer Diagnostics Market Players Strategic Assessments of Major Suppliers and Emerging Market Entrants	Sep 2009	£1,325
The German Cancer Diagnostics Market	Sep 2009	£2,465
Cancer Diagnostic Testing A Global Market Overview - Facilities, Test Volumes, and Sales Forecasts by Country	Sep 2009	£390
The Italian Cancer Diagnostics Market	Sep 2009	£2,465
The UK Cancer Diagnostics Market	Sep 2009	£2,465
The French Cancer Diagnostics Market	Sep 2009	£2,465
Cancer Diagnostic Technologies Assessment of Current and Emerging Technologies, and Their Potential Market Applications	Sep 2009	£1,020
The US Cancer Diagnostics Market	Sep 2009	£4,450
Cancer Diagnostics Market New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks	Sep 2009	£300
Cancer Diagnostic Testing Instrumentation Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers	Sep 2009	£300
Current and Emerging Cancer Diagnostic Tests Emerging Assays and Companies Developing New Technologies and Products	Sep 2009	£1,715
The Japanese Cancer Diagnostics Market	Sep 2009	£3,425
Competitive Outlook on Lung Cancer Drug Development The Missing Handbook to New Product Planning and Portfolio Planning	Aug 2009	£2,240
CHK and KSP/Eg5 Inhibitors Competitor Analysis	Aug 2009	£155
Cancer Drug Discoveries: Colorectal Cancer What the future holds	Jul 2009	£1,295
The Vaccines Market Outlook to 2014 Competitive Landscape, Pipeline Analysis, Growth Opportunities and Market Forecasts	Jul 2009	£2,305
Inflammatory Bowel Disease Market Forecast	Jul 2009	£9,140
IGF-1R Antagonists Competitor Analysis	Jul 2009	£225
Immunotoxins Competitor Analysis	Jul 2009	£135
World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024	Jul 2009	£1,499
HDAC Inhibitors Competitor Analysis	Jul 2009	£355
PI3K-Akt-mTOR Pathway Inhibitors Competitor Analysis	Jul 2009	£445
Osteoporosis Market Forecast	Jul 2009	£9,140
Attention-Deficit Hyperactivity Disorder Market Forecast	Jul 2009	£9,140
Bcr-Abl Kinase Inhibitors Competitor Analysis	Jul 2009	£180
Pipeline and Commercial Insight: Osteoporosis Novel agents to battle for payer acceptance	Jul 2009	£9,140
Lymphoma Drug Development Strategies at Work Define Your Competition	Jun 2009	£1,780
Insulin Delivery Devices Market Analysis and Future Forecast	Jun 2009	£510
Global Diabetes Market	Jun 2009	£3,910
Chinese Markets for Blood Disease Drugs	Jun 2009	£2,405
Asthma and COPD Market Forecast	Jun 2009	£9,140
Chinese Markets for Asthma Treatment Drugs	Jun 2009	£2,405
HIV Market Forecast	Jun 2009	£9,140
Forecast Insight: HIV Cross-class fixed dose combinations drive continued growth	Jun 2009	£9,140
MEK Inhibitors Competitor Analysis	Jun 2009	£135
Advances in Ophthalmology Markets in The Treatment of Eye Disorders and Corrective Vision, 2nd Ediiton	Jun 2009	£2,105
Allergy Drug Pipeline and R&D 2009 Emerging Technologies, Companies, Products, Applications, Sales & Market Share, and Worldwide Outlook	Jun 2009	£990
Chinese Markets for Leukemia Treatment Drugs	Jun 2009	£2,405
Aurora Kinase Inhibitors Competitor Analysis	Jun 2009	£155
Antibody-Drug Conjugates (ADC) Competitor Analysis	Jun 2009	£225
Chinese Markets for Hepatitis Treatment Drugs	Jun 2009	£2,405
Chinese Markets for Anti-Infectious Disease Drugs	Jun 2009	£2,405
Immunocytokines Competitor Analysis	Jun 2009	£135
Therapeutic Peptides in Oncology Favorable Conditions But Where to Commercialize?	May 2009	£3,235
Elastase Inhibitors Competitor Analysis	May 2009	£180
Raf Inhibitors Competitor Analysis	May 2009	£180
Novel Mitotic Kinase Inhibitors Competitor Analysis	May 2009	£315
World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The	May 2009	£2,400
H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)	May 2009	£480
Chronic Obstructive Pulmonary Disease (COPD) Market: An Analysis	May 2009	£485
Ras-Raf-MEK-ERK Inhibitors Competitor Analysis	May 2009	£315
China Asthma Drug Market Report The Chinese Asthma Drug Drug Utilization	May 2009	£2,785
The Toolkit for Diabetes MSL Programs	May 2009	£4,760
PARP Inhibitors Competitor Analysis	Apr 2009	£89
Prostate Cancer Therapeutics	Apr 2009	£2,375
Hypoxia-Inducible Factor (HIF) Competitor Analysis	Apr 2009	£89
Leukemia A Competitive Analysis to New Products, Portfolio Planning, Licensing & Acquisition Through Pipeline Benchmarking	Apr 2009	£1,780
Pipeline Insight: Hematological Malignancies Companies target niche indications to facilitate market entry	Apr 2009	£6,950
Diabetes, Metabolic Syndrome and Cardiovascular Disease	Apr 2009	£2,105
Blood Glucose Testing and Diabetes Management	Apr 2009	£2,075
European HIV/AIDS Therapeutics Markets	Apr 2009	£3,910
Hepatitis C Virus And Therapeutics	Apr 2009	£2,375
Sphingosine-1-Phosphate (S1P) Competitor Analysis	Apr 2009	£89
Multiple Myeloma Therapeutics	Apr 2009	£2,375
Alzheimer's Disease: Markets, Pipeline and Opportunities 2009	Apr 2009	£1,855
Looking at the Cancer Therapy Market	Apr 2009	£420
Future of the Diabetes Care Devices Market to 2015	Mar 2009	£2,105
CD3 Antagonists Competitor Analysis	Mar 2009	£180
The Global Multiple Sclerosis Market 2009-2024	Mar 2009	£1,499
Multiple Sclerosis Treatment Market Opportunities for Oral Drugs	Mar 2009	£485
Global Alzheimer Drugs Market An Analysis	Mar 2009	£425
Amyotrophic Lateral Sclerosis/ Lou Gehrig's disease Competitor Analysis	Mar 2009	£180
Stakeholder Opinions: Pancreatic Cancer - Gemzar dominance will continue among high levels of persistent unmet needs Healthcare	Mar 2009	£2,315
Stakeholder Opinions: Physician perception of biologics in autoimmune disease - Targeted detailing is the key to success Healthcare	Mar 2009	£2,315
Stakeholder Insight: Psoriasis - Biologics are yet to make topical treatments obsolete Healthcare	Mar 2009	£8,070
Stakeholder Opinions: Cystic Fibrosis - A pipeline full of hope Healthcare	Mar 2009	£2,315
p38 MAPK Inhibitors Competitor Analysis	Mar 2009	£180
EpCAM Antagonists Competitor Analysis	Mar 2009	£89
Attention-Deficit Hyperactivity Disorder (ADHD) Competitor Analysis	Mar 2009	£180
Opportunities Assessment for Hepatitis B Therapeutics Market in Indonesia	Mar 2009	£3,605
China Allergy Drug Market Report The Chinese Allergy Cancer Drug Utilization	Mar 2009	£2,785
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment	Mar 2009	£180
China Senile Dementia Drug Market Report The Chinese Dementia Drug Utilization	Mar 2009	£4,950
TNF Antagonists & Agonists Competitor Analysis	Feb 2009	£270
Interleukin-6 (IL-6) and Receptor (IL-6R) Antagonists Competitor Analysis	Feb 2009	£89
Chinese Markets for Prostate Cancer Treatment Drugs	Feb 2009	£2,405